Dr Falade-Nwulia is an Associate Professor and director of the Center for Substance Use and Infectious Disease care integration in the Division of Infectious Diseases at the Johns Hopkins University School of Medicine. She completed her internal medicine residency and infectious at the infectious disease fellowship at the Johns Hopkins School of Medicine. Her research program focuses on development, implementation and evaluation of novel strategies integrating behavioral and biomedical interventions with an overarching goal of improving viral hepatitis, HIV and substance use outcomes. Dr. Falade-Nwulia leverages expertise from a range of disciplines including medicine, epidemiology, social sciences and technology to develop and implement low threshold integrated infectious disease and substance use care strategies. She is also an active viral hepatitis, HIV and substance use disorder care provider.

Prof Linda-Gail Bekker is the Chief Executive Officer of the Desmond Tutu Health Foundation and Director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa. Prof Bekker is a physician, scientist and infectious disease specialist. Her research interests include programmatic and action research around antiretroviral roll-out and TB integration, prevention of HIV in women, youth and MSM. Prof Bekker serves on numerous international scientific and advisory committees. She is a A+ rated scientist, has published >700 peer-reviewed papers.

Professor Jason Grebely is Head of the Hepatitis C and Drug Use Group at the Kirby Institute, UNSW Sydney, and President of INHSU. A leading expert in HCV epidemiology, testing, and treatment, his research focuses on improving care for people who use drugs, including novel diagnostic and treatment strategies.

Dr Huan-Keat Chan holds a Bachelor’s Degree in Pharmacy from Universiti Sains Malaysia (2008) and a Doctorate in Social and Administrative Pharmacy (2023). He currently serves at the Institute for Clinical Research, Ministry of Health Malaysia, following a three-year tenure as Special Officer to the Deputy Director-General of Health. His research within the Ministry spans pharmacy practice, public health, and internal medicine, with over 100 peer-reviewed publications. His notable work on hepatitis C covers the full care continuum in Malaysia, from screening and treatment decentralization to improving treatment access and cost analyses.